** Shares of Kleenex tissue maker Kimberly-Clark KMB.N down 1.1% at $129.95 premarket
** Co's Q4 adjusted EPS of $1.50 narrowly misses estimates of $1.51 - data compiled by LSEG
** Q4 revenue falls 1.8% to $4.93 billion, but beats estimates of $4.86 billion
** Co also sees adjusted EPS for fiscal 2025 to rise by mid-to-high single-digits compared with estimates of 3.2% increase
** KMB rose ~8% in 2024
(Reporting by Neil J Kanatt in Bengaluru)
((Neil.JKanatt@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.